AS2AMR
Venue Program Speakers Registration André Gratia
Contact
AS2AMR
Venue Program Speakers Registration André Gratia
Large decorational arc svg
Large decorational arc svg
One Health In Focus - 25 - 28 may 2025

One Health In Focus - AS2AMR

25 - 28 may 2025

BRUSSELS
PALACE OF THE ACADEMIES

One Health In Focus - 25 - 28 may 2025
Register here!
100 YEARS OF BACTERIOCINS – ADVANCING SOLUTIONS TO ANTIMICROBIAL RESISTANCE

100 YEARS OF BACTERIOCINS – ADVANCING SOLUTIONS TO ANTIMICROBIAL RESISTANCE

On the occasion of the 100th anniversary of the discovery of bacteriocins by the Belgian researcher André Gratia, this meeting will address the global health challenge of antimicrobial resistance with a focus on Advancing Solutions to AntiMicrobial Resistance (AS2AMR) and will be jointly organized with the 2nd Bacteriocin International Conference (BIC2025). The event will take place from May 25 to 28, 2025, at the Palace of the Academies in Brussels, Belgium.

On Sunday, May 25, the introductory presentations will cover the scientific and societal dimensions of AMR. Monday’s talks will deep dive into the issues we are facing on the diverse aspects of AMR, spanning human and animal health, agriculture, the environment, and food safety, while Tuesday will feature presentations exploring current strategies and potential future approaches to combat AMR. The final day will be dedicated to bacteriocins as one of the most promising alternatives to deal with the AMR issues.

More information

THE VENUE

navigation icon Palace of the Academies, Brussels

One of the buildings to which the Palace Square owes its name is the Palace of the Academies, which currently houses most of the Academies of Belgium, including the KVAB. Between 1828 and 1830, it was the home of Crown Prince William of Orange-Nassau and his wife Anna Pavlovna, daughter of Czar Paul and Grand Duchess of Russia. For a certain period it was also the residence of Crown Prince Leopold, at that time holding the title of Duke of Brabant, to which Hertogstraat (“Duke street”) refers. The palace is a late but pure example of neoclassicism, the palace style of the Enlightenment. This architectural gem was designed according to pure geometric proportions, renaissance symmetry and axiality.

Decorational arc svg
Large decorational arc svg
THE VENUE

Steering Committee

arrow left black arrow left black
arrow right arrow right
Decorational grey arc
AERTSEN Abram
Speaker icon AERTSEN Abram
BOLAND Cécile
Speaker icon BOLAND Cécile
BORRERO DEL PINO Juan
Speaker icon BORRERO DEL PINO Juan
COS Paul
Speaker icon COS Paul
DEPREZ Mimi
Speaker icon DEPREZ Mimi
DRIDER Djamel
Speaker icon DRIDER Djamel
GABANT Philippe
Speaker icon GABANT Philippe
HÖFTE Monica
Speaker icon HÖFTE Monica
LEYS Natalie
Speaker icon LEYS Natalie
MAHILLON Jacques
Speaker icon MAHILLON Jacques
PIERARD Denis
Speaker icon PIERARD Denis
THIRY Damien
Speaker icon THIRY Damien
THIRY Etienne
Speaker icon THIRY Etienne
VAN DER HENST Charles
Speaker icon VAN DER HENST Charles
VAN HOORDE Koenraad
Speaker icon VAN HOORDE Koenraad

PROGRAM

navigation icon Palace of the Academies, Brussels
Sunday May 25
Monday May 26
Tuesday May 27
Wednesday May 28
Time
Topic
14:00
Registration
16:00
Welcome and opening remarks
16:10
Official address
16:40
Playing chicken with antibiotics: global trends in antimicrobial resistance in animals and humans
Thomas Van Boeckel – University of Zurich (Switzerland)
17:10
Phages as friends and enemies in foods
Keynote speaker: Sylvain Moineau – Université Laval, Québec (CAN)
18:00
Welcome cocktail
8:50
Welcome day 1: One-Health - One-World challenges - Jacques Mahillon – UCLouvain, NaCoMi
Antimicrobial Resistance (AMR) in human and animal medicine – Chairs: Denis Piérard & Etienne Thiry
9:00
How is the antimicrobial selection pressure evolving in Belgium healthcare ?
Boudewijn Catry – Sciensano, Brussels (BEL)
9:25
The impact of COVID-19 on the antibiotic resistance in Gram-negative bacteria within Brussels' Intensive Care Units
Marco Moretti – VUB, Brussels (BEL)
9:50
Streptococcus suis infections in pigs, viewed from a one-health perspective
Dominiek Maes – UGent (BEL)
10:15
AMCRA, tackling antibiotic resistance in animals with a One-Health perspective
Fabiana Dal Pozzo – AMCRA, Brussels (BEL)
10:40
Coffee break
AMR in feed and food – Chairs: Jacques Mahillon & Koenraad Van Hoorde
11:05
Studies in wax moths, mice and humans establish that “Acceptable Daily Doses” of ciprofloxacin induce dysbiosis and antimicrobial resistance
Chris Kenyon – UAntwerp (BEL)
11:30
Metagenomics for AMR detection in food and feed: lessons learned from One Health applications and challenges ahead
Sigrid De Keersmaecker – Sciensano, Brussels (BEL)
11:55
AMR bacteria and gene flow in the food system: Risks and mitigation measures
Pier Sandro Cocconcelli – Univ. Cattolica del Sacro Cuore, Piacenza (ITA) EFSA
12:20
Lunch
AMR in agriculture and the environment – Chairs: Monica Höfte & Natalie Leys
14:00
Antifungal resistance in plant pathogenic fungi in North West Europe
Monica Höfte – UGent (BEL)
14:25
Land use drives drug resistance in a human fungal pathogen
Eveline Snelders – Wageningen University (NLD)
14:50
AMR in the clinical environment
Surbhi Malhotra-Kumar – UAntwerp (BEL)
15:15
Antimicrobial resistant pathogens in space environment: challenges and possible solutions
Elisabeth Grohmann – Berlin University of Applied Sciences (DEU)
15:40
Coffee break
Current regulations, legislations and challenges – Chair: Philippe Gabant
16:05
Where are the new antimicrobials? A tale of hope and despair
Pieter-Jan Ceyssens – Sciensano, Brussels (BEL)
16:30
Bacteriophages - New tool for One Health Approach to Mitigate AMR - Regulatory Challenges
Jaroslaw Dastych – PhageEU & Proteon Pharmaceuticals, Lodz (POL)
16:55
Round Table
8:50
Welcome day 2: New strategies, new tools, new solutions - Jacques Mahillon – UCLouvain – NaCoMi (BEL)
Guardians of health: strategies for preventing infectious diseases – Chairs: Paul Cos
9:00
Rapid diagnostics for UTIs and sepsis
Wouter Van der Wijngaart – Royal Institute of Technology Stockholm (SWE)
9:25
Decolonization strategies against multidrug resistant organisms in the Intensive Care Unit
Stijn Blot – UGent (BEL)
9:50
Novel vaccines for respiratory viral infections: Can they reduce both viral disease burden and antibiotic usage?
Peter Delputte – UAntwerp (BEL)
10:15
TBD
Ahalieyah Anantharajah - UCLouvain (BEL)
10:40
Coffee break
New AB and beyond – Chairs: Charles Van der Henst & Cécile Boland
11:05
Next-Generation Antibiotics: Addressing Tomorrow's Challenges
Françoise Van Bambeke – UCLouvain (BEL)
11:30
Antimicrobial Peptides in preventive medicine: bridging fundamental science and clinical application
Laurence Van Moll - Milan Wouters – UAntwerp (BEL)
11:55
Bacterial quorum sensing systems as targets for antivirulence therapy
Tom Defoirdt – UGent (BEL)
12:20
Lunch
Phage and phage-related antimicrobial molecules – Chairs: Abram Aertsen & Damien Thiry
14:00
Expanding phage therapy treatment to Hidradenitis Suppurativa
Rob Lavigne – KU Leuven (BEL)
14:25
Environment-dependent phage evolution destabilizes the bacteria-phage coexistence mediated by phase variation
Nicolas Wenner – UBasel (Switzerland)
14:50
Clinical aspects of phage therapy: a Belgian experience
Sarah Djebara – Queen Astrid Military Hospital, Brussels (BEL)
15:15
Harnessing bacteriophage-derived particles for precision genetic circuit delivery: Antimicrobials and gene editing tools
Jesus Fernandez – Eligo Bioscience, Paris (FRA)
15:40
Coffee break
Novel technologies and future legislations – Chair: Philippe Gabant
16:05
Implementing personalised phage therapy
Jean-Paul Pirnay – Queen Astrid Military Hospital, Brussels (BEL)
16:30
Engineering customized and microbiome-friendly protein-based antibiotics
Yves Briers – UGent (BEL)
16:55
Health emergency preparedness and response authority (HERA)
Inmaculada Navarro – European Commission - DG HERA, Brussels (BEL)
17:20
Round Table
8:50
André Gratia’s ULB years: from early microbiology to major breakthroughs
Marius Gilbert – ULB, Brussels (BEL)
9:00
Homage to André Gratia (1893-1950), the father of bacteriocins
Vincent Geenen – ULiège (BEL)
9:10
Bacteriocins over the years: from discovery to ecological roles and therapeutic perspectives
Sylvie Rebuffat – Muséum national d'Histoire naturelle, Paris (FRA)
Discoveries of new bacteriocins – Chair: Drider Djamel
9:40
Trans-kingdom conservation of structure and mechanism in defensin-like bacteriocins
Ivan Sugrue – University College Cork (IRL)
10:05
An ABC exporter-GntR regulator system as a bacteriocin sensor for the control of antimicrobial peptide multi-resistance in streptococci
Julien Damocsi – UCLouvain, Louvain-la-Neuve (BEL)
10:30
Bacteriocins as a new strategy to inhibit the opportunistic human pathogen Streptococcus pneumoniae
Johann Mignolet – University of Lausanne (CHE)
10:55
Coffee break
News from the bench – Chair: Borrero Del Pino Juan
11:20
Design, engineering and control of microbial communities
Chris P. Barnes – University College London (GBR)
11:45
Invited Flash Speakers
12:25
Lunch
A new age for bacteriocins I – Chair: Johann Mignolet
14:00
Exploring circular bacteriocins: new approaches for production and engineering
Borrero Del Pino Juan – Universidad Complutense de Madrid (ESP)
14:25
Bacteriocins: Effective Food Preservatives or a Work in Progress ?
Célia Costa Gomes da Silva – Universidade dos Açores (PRT)
14:50
The Bac-Bac network: bacteriocins and bacteriophages in food biotechnology
Beatriz Martínez – IPLA, Villaviciosa (ESP)
15:15
Targeting outer membrane assembly machineries for new antibiotics
Jean François Collet – UCLouvain, Brussels (BEL)
15:40
Coffee break
A new age for bacteriocins II – Chairs: Philippe Gabant & Drider Djamel
16:00
The human microbiome as a source of, and target for novel antimicrobial peptides
Andreas Peschel – Tübingen University (DEU)
16:25
The Man-PTS paradox: why do so many bacteriocins target the same receptor?
Tamara Aleksandrzak-Piekarczyk – IBB, Warsaw (POL)
16:50
From bench to market, the amazing journey of the bacteriocin pediocin PA-1 and its analogues
Eric Biron – Laval University, Québec (CAN)

Functional & Statistical Cookies

These cookies are necessary for the proper functioning of our website. Any analytical data that is collected is completely anonymous.
More information about the privacy and cookie policy.

I accept all cookies

Full Conference Tickets

navigation icon Access from 25 to 28 May
including 2nd BIC Conference

Student Registration

always available

early bird rate icon
€ 350 inc. 21% vat
Buy tickets

Regular rate

Until 30/04

Regular rate icon
€ 550 inc. 21% vat
€ 350 for students and postdocs only (requires a valid student ID or certificate of postdoc position)
Buy tickets

Late rate

As of 30/04

Late rate icon
€ 600 inc. 21% vat
Available soon

Partners

UCLouvain logo Belgian Society for Microbiology Logo FNRS KU Leuven logo U Antwerpen logo UGent logo logo Liege Universite logo Université de Namur logo VUB logo Sciensano logo Queen Astrid Military Hospital logo Belgian Society for Food Microbiology logo UMons logo

Sponsors

bruker logo BiHauts Eco de France logo SFM logo SFM logo
Horizon linework

AS2AMR

Legal

Terms & conditions

Disclaimer

Privacy & cookies

Contact

Registrations

Event Masters NV

Brownfieldlaan 37-1, B-2830 Willebroek

BE0455 164 778

as2amr@eventmasters.eu

Partnerships

UCLouvain - ADFI

Place de l'Université 1 Bte L0.03.31, B-1348 Louvain-la-Neuve

BE0419 052 272

jacques.mahillon@uclouvain.be

Copyright © AS2AMR 2025

Website design & development by Logo Popkorn